logo-large
  • Browse Categories

Publications by authors named "Bas M Middelkoop"

Claim this Profile
R
Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4.
Marloes Stam, Camiel A Wijngaarde, Bart Bartels, Fay-Lynn Asselman, Louise A M Otto, Bas M Middelkoop

Brain Commun· December 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials.
Ruben P A van Eijk, Stavros Nikolakopoulos, Kit C B Roes, Bas M Middelkoop, Toby A Ferguson

J Neurol Neurosurg Psychiatry· December 2019


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
Henk-Jan Westeneng, Thomas P A Debray, Anne E Visser, Ruben P A van Eijk, James P K Rooney, Bas M Middelkoop

Lancet Neurol· May 2018


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: